Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-005235-96Phase 2Completed
Phase 2, randomised, double-blind trial of botulinum toxin type A in glabellar furrowing (2 arms), sponsored by Cranley Clinic. Primary endpoint: Qualitative Rating of Glabellar Rhytids. Started Nov 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-005235-96.